U.S. flag

An official website of the United States government

Display Settings:

Format
Sort by

Send to:

Choose Destination

Links from Books

Items: 5

1.
Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice
Hua Zhang, Calvin Q Pan, Qiumei Pang, Ruihua Tian, Miaoe Yan, Xin Liu
Hepatology. 2014 Aug; 60(2): 468–476. Published online 2014 Jun 24. doi: 10.1002/hep.27034
PMCID:
PMC4282428
AbstractArticlePDF–602K
2.
Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B
Eun Hye Kim, Hana Park, Kun Ho Lee, Sang Hoon Ahn, Seung-Min Kim, Kwang-Hyub Han
Clin Mol Hepatol. 2013 Mar; 19(1): 82–86. Published online 2013 Mar 25. doi: 10.3350/cmh.2013.19.1.82
PMCID:
PMC3622860
AbstractArticlePDF–580K
3.
Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
Y Wang, S Thongsawat, E J Gane, Y-F Liaw, J Jia, J Hou, H L Y Chan, G Papatheodoridis, M Wan, J Niu, W Bao, A Trylesinski, N V Naoumov
J Viral Hepat. 2013 Apr; 20(4): e37–e46. Published online 2012 Dec 27. doi: 10.1111/jvh.12025
PMCID:
PMC3618368
AbstractArticlePDF–189K
4.
Myotoxicity of telbivudine in pre-existing muscle damage
Josef Finsterer, Leyla Ay
Virol J. 2010; 7: 323. Published online 2010 Nov 17. doi: 10.1186/1743-422X-7-323
PMCID:
PMC2998482
AbstractArticlePDF–185K
5.
Nonclinical Safety Profile of Telbivudine, a Novel Potent Antiviral Agent for Treatment of Hepatitis B
Edward G. Bridges, Jules R. Selden, Shouqi Luo
Antimicrob Agents Chemother. 2008 Jul; 52(7): 2521–2528. Published online 2008 May 12. doi: 10.1128/AAC.00029-08
PMCID:
PMC2443876
AbstractArticlePDF–92K

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center